Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

NCT02177838 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Stage III Squamous Cell Carcinoma of the Hypopharynx
Stage III Squamous Cell Carcinoma of the Larynx
Stage III Squamous Cell Carcinoma of the Oropharynx
Stage III Verrucous Carcinoma of the Larynx
Stage IV Squamous Cell Carcinoma of the Hypopharynx
Stage IVA Squamous Cell Carcinoma of the Larynx
Stage IVA Squamous Cell Carcinoma of the Oropharynx
Stage IVA Verrucous Carcinoma of the Larynx
Stage IVB Squamous Cell Carcinoma of the Larynx
Stage IVB Squamous Cell Carcinoma of the Oropharynx
Stage IVB Verrucous Carcinoma of the Larynx
Tongue Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
RADIATION: external beam radiation therapy
OTHER: laboratory biomarker analysis

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]